Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hemoglobinopathies × Glucose Tolerance Test × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Diabetes Mellitus 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Neoplasms 1 Lymphoma 1 Iron Overload 1 Hemoglobinopathies 1 Glucose Metabolism Disorders 1 Glucose Intolerance 1 Fibrous Dysplasia, Polyostotic 1 Fibrous Dysplasia of Bone 1 Fatty Liver 1

Interventions

fludarabine 2 fludarabine phosphate 1 Thiotepa 1 Melphalan 1 Glucose Tolerance Test 1 Continuous Glucose Monitoring 1 Clofarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03141398 2017-07-26

CGMs

Hamad Medical Corporation

LymphoidOther hematologic neoplasm

Hemoglobinopathies, Lymphoma, Iron Overload, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡